# ReShape Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/reshape-medical

- Industry: Medical Devices & Equipment
- Headquarters: San Clemente, US
- Website: www.reshapeready.com
- Total disclosed funding: $81M
- Latest round: Series D (Aug 26, 2015)
- Investors on record: 6

## About

ReShape Medical, Inc. is a healthcare company focused on developing medical devices and solutions for obesity management, offering innovative products that support weight loss and metabolic health.Founded in 2008 in San Clemente, US, ReShape Medical, Inc. specializes in obesity treatment solutions. In October 2017, the company was acquired by EnteroMedics for USD 38 mn. The Firm has completed 12 deals to date, with its latest funding round being an Add-on Trade Sale.ReShape Medical, Inc. specializes in innovative medical devices for obesity and metabolic diseases. Its flagship product is the LAP-BAND®, an adjustable gastric band designed for effective long-term weight management. Additionally, the ReShape Vest™ offers a reversible, non-invasive alternative to traditional surgery for weight loss, catering to healthcare professionals, hospitals, and patients primarily in North America and select international markets.ReShape Medical, Inc. generates revenue through the sale of its medical devices, including the LAP-BAND® and ReShape Vest™, to healthcare providers. The company operates on a business-to-business model, partnering with clinics and hospitals for its products. While specific pricing details are not disclosed, these flagship products significantly contribute to the company's revenue from obesity treatment solutions.ReShape Medical, Inc. plans to utilize the recent funding from its acquisition in October 2017 to enhance its product line and expand its market reach. The company is focusing on developing new products aimed at improving obesity treatment outcomes and targeting new geographic markets. Specific plans and timelines for product launches and expansions have not been detailed.

## Funding rounds

- Series D, Aug 26, 2015, $38M — US Venture Partners, Venture Investors, SV Health Investors, New Leaf Venture Partners, Endeavour Vision, HealthCor Group
- Series C, Oct 22, 2012, $16M — US Venture Partners, SV Health Investors, New Leaf Venture Partners
- Series B, Feb 3, 2009, $20M — US Venture Partners, SV Health Investors, New Leaf Venture Partners
- Series A, Aug 22, 2007, $3M — SV Health Investors, New Leaf Venture Partners
- Series A, Apr 28, 2006, $4M — SV Health Investors, New Leaf Venture Partners
- Seed, Jun 1, 2005 — SV Health Investors

## Investors

- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Seed, Series A, Series B, Series C, Series D
- New Leaf Venture Partners (https://capitalatlas.ai/funds/new-leaf-venture-partners) — Series A, Series B, Series C, Series D
- US Venture Partners (https://capitalatlas.ai/funds/us-venture-partners) — Series B, Series C, Series D
- Venture Investors — Series D
- Endeavour Vision (https://capitalatlas.ai/funds/endeavour-vision) — Series D
- HealthCor Group (https://capitalatlas.ai/funds/healthcor-group) — Series D